PDP1 and malignant colon neoplasm: In this study, we generated colon cancer xenograft tumors and examined changes in cellular metabolism by immunohistochemical staining for phospho‐PDH (a marker of PDK activity), and markers of Wnt signaling (LEF‐1, β‐catenin).